1
|
Jorge EC, Martínez NN, González MJ, Sánchez SV, Robino L, Morales JO, Scavone P. Gold-, silver- and magnesium-doped zinc oxide nanoparticles prevents the formation of and eradicates bacterial biofilms. Nanomedicine (Lond) 2023. [PMID: 37254888 DOI: 10.2217/nnm-2022-0239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
Abstract
Aim: This work aimed to synthesize magnesium-doped zinc oxide, silver and gold nanoparticles (Nps) and to evaluate their potential to prevent and eradicate Escherichia coli, Proteus mirabilis, Staphylococcus aureus, Acinetobacter baumannii and Pseudomonas aeruginosa biofilms. Materials & methods: The Nps were synthesized by precipitation and metallic reduction techniques. Physicochemical and biological characterization of Nps was performed. Results: All the Nps tested were able to inhibit the formation of E. coli, P. mirabilis, S. aureus and A. baumannii biofilms. The effects on the eradication of preformed biofilms were variable, although all the Nps tested were able to eradicate A. baumannii biofilms. Conclusion: The observed effects make the Nps suitable for coating surfaces and/or antibiotic carriers with medical interest.
Collapse
Affiliation(s)
- Erlen Cruz Jorge
- Departamento de Microbiología, Laboratorio de Biofilms Microbianos, Instituto de Investigaciones Biológicas Clemente Estable, Av. Italia 3318 PC 11600, Montevideo, Uruguay
| | - Nicolás Navarro Martínez
- Departamento de Microbiología, Laboratorio de Biofilms Microbianos, Instituto de Investigaciones Biológicas Clemente Estable, Av. Italia 3318 PC 11600, Montevideo, Uruguay
- Advanced Center for Chronic Diseases (ACCDiS), Sergio Livingstone 1007, Independencia, PC 8380000, PC Santiago, Chile
- Center of New Drugs for Hypertension (CENDHY), Santos Dumont 964, Independencia, PC 8380000, Santiago, Chile
| | - María José González
- Departamento de Microbiología, Laboratorio de Biofilms Microbianos, Instituto de Investigaciones Biológicas Clemente Estable, Av. Italia 3318 PC 11600, Montevideo, Uruguay
| | - Sofía V Sánchez
- Advanced Center for Chronic Diseases (ACCDiS), Sergio Livingstone 1007, Independencia, PC 8380000, PC Santiago, Chile
- Center of New Drugs for Hypertension (CENDHY), Santos Dumont 964, Independencia, PC 8380000, Santiago, Chile
- Departamento de Ciencias y Tecnologías Farmacéuticas, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santos Dumont 964, Independencia, PC 8380000, Santiago, Chile
| | - Luciana Robino
- Departamento de Bacteriología y Virología, Instituto de Higiene, Facultad de Medicina, Universidad del República, Alfredo Navarro 3051, PC 11600 Montevideo, Uruguay
| | - Javier O Morales
- Advanced Center for Chronic Diseases (ACCDiS), Sergio Livingstone 1007, Independencia, PC 8380000, PC Santiago, Chile
- Center of New Drugs for Hypertension (CENDHY), Santos Dumont 964, Independencia, PC 8380000, Santiago, Chile
- Departamento de Ciencias y Tecnologías Farmacéuticas, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santos Dumont 964, Independencia, PC 8380000, Santiago, Chile
| | - Paola Scavone
- Departamento de Microbiología, Laboratorio de Biofilms Microbianos, Instituto de Investigaciones Biológicas Clemente Estable, Av. Italia 3318 PC 11600, Montevideo, Uruguay
| |
Collapse
|
2
|
Sánchez SV, Navarro N, Catalán-Figueroa J, Morales JO. Nanoparticles as Potential Novel Therapies for Urinary Tract Infections. Front Cell Infect Microbiol 2021; 11:656496. [PMID: 33954121 PMCID: PMC8089393 DOI: 10.3389/fcimb.2021.656496] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Accepted: 03/23/2021] [Indexed: 12/21/2022] Open
Abstract
Urinary tract infection (UTI) is one of the most common reasons for antibiotic treatment. Nevertheless, uropathogens are steadily becoming resistant to currently available therapies. In this context, nanotechnology emerges as an innovative and promising approach among diverse strategies currently under development. In this review we deeply discuss different nanoparticles (NPs) used in UTI treatment, including organic NPs, nanodiamonds, chemical and green synthesized inorganic NPs, and NPs made of composite materials. In addition, we compare the effects of different NPs against uropathogens in vivo and in vitro and discuss their potential impact the in the near future.
Collapse
Affiliation(s)
- Sofía V Sánchez
- Department of Pharmaceutical Science and Technology, School of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.,Center of New Drugs for Hypertension (CENDHY), Santiago, Chile.,Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile
| | - Nicolás Navarro
- Department of Pharmaceutical Science and Technology, School of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.,Center of New Drugs for Hypertension (CENDHY), Santiago, Chile.,Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile
| | - Johanna Catalán-Figueroa
- Departamento Farmacología, Facultad de Ciencias Químicas, Instituto de Farmacología experimental de Córdoba (IFEC-CONICET), Universidad Nacional de Córdoba, Córdoba, Argentina.,Facultad de Medicina, Escuela de Química y Farmacia, Universidad Católica del Maule, Talca, Chile
| | - Javier O Morales
- Department of Pharmaceutical Science and Technology, School of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.,Center of New Drugs for Hypertension (CENDHY), Santiago, Chile.,Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile
| |
Collapse
|